This archive contains the following articles listed by volume, issue and page number:
 |
|
|
Volume 3, 1999 Articles |
Title (Click for Details) |
Vol/Issue |
Page |
Issues and Opportunities: Compounding for Dentistry |
Vol. 3 No. 1 |
4 |
Compounding Mouthwashes and Rinses for Oral Ulcerations |
Vol. 3 No. 1 |
8 |
Oral Ulceration Mouthwash |
Vol. 3 No. 1 |
10 |
Mouthwash, Toothpaste and Toothgel Vehicles |
Vol. 3 No. 1 |
12 |
Mouthwash/Gargle Formulation No. 1 |
Vol. 3 No. 1 |
12 |
Mouthwash/Gargle Formulation No. 2 |
Vol. 3 No. 1 |
12 |
Mouthwash/Gargle Formulation No. 3 |
Vol. 3 No. 1 |
12 |
Toothgel Vehicle |
Vol. 3 No. 1 |
13 |
Toothpaste Vehicle |
Vol. 3 No. 1 |
13 |
Toxicity of Amalgams |
Vol. 3 No. 1 |
14 |
A Brief Look at the History of Oral Hygiene |
Vol. 3 No. 1 |
17 |
Dental Compounding in Denmark |
Vol. 3 No. 1 |
18 |
The Basics of Compounding: Compounding Ointments and Pastes |
Vol. 3 No. 1 |
22 |
FDAMA Proposed List of Agents Not to be Compounded due to Withdrawal for Safety/Efficacy Concerns |
Vol. 3 No. 1 |
25 |
Coenzyme Q10: It's Everywhere |
Vol. 3 No. 1 |
30 |
Ubidicarenone (Coenzyme Q10) 200-mg Gelatin Troche |
Vol. 3 No. 1 |
32 |
Case Reports: Steroid Substitute Treatment for Psoriasis; Metronidazole for Odor Related to Untreated Metastatic Breast Tumor |
Vol. 3 No. 1 |
34 |
Audit Problems for Compounding Pharmacies |
Vol. 3 No. 1 |
36 |
HRT Marketing Tip |
Vol. 3 No. 1 |
37 |
Ringworms in Cats |
Vol. 3 No. 1 |
38 |
Profile of a Practice |
Vol. 3 No. 1 |
39 |
Dental Cavity Varnish |
Vol. 3 No. 1 |
42 |
Dental Chemical Curettage Agent |
Vol. 3 No. 1 |
43 |
Dental Pressure Indicating Paste (PIP) |
Vol. 3 No. 1 |
44 |
Fluoride Lozenges |
Vol. 3 No. 1 |
45 |
Gag Tablet |
Vol. 3 No. 1 |
46 |
Gum Massage Gel |
Vol. 3 No. 1 |
47 |
Misoprostol 0.0024% and Lidocaine 1% in Glycerin Mouth Paint |
Vol. 3 No. 1 |
48 |
Misoprostol Mucoadhesive Anesthetic Powder |
Vol. 3 No. 1 |
49 |
Potassium Nitrate Desensitizing Gel |
Vol. 3 No. 1 |
50 |
Tetracycline 2.4% or Metronidazole 10% Periodontal Gel |
Vol. 3 No. 1 |
51 |
Antioxidants, Featured Excipient: |
Vol. 3 No. 1 |
52 |
Standard Operating Procedure for Performing Physical Quality Assessment of Suppositories, Troches, Lollipops and Sticks |
Vol. 3 No. 1 |
56 |
Calculations |
Vol. 3 No. 1 |
58 |
Stability of Four Commercial Products Delivered by Mail Order |
Vol. 3 No. 1 |
59 |
Y-Site Stability of Fosphenytoin and Sodium Phenobarbital |
Vol. 3 No. 1 |
64 |
Five-Day Stability of Vinorelbine in 5% Dextrose Injection and in 0.9% Sodium Chloride Injection at Room Temperature |
Vol. 3 No. 1 |
67 |
Men's Health: Practical Solutions to a Profoundly Underrated Health-Care Crisis |
Vol. 3 No. 2 |
76 |
Male Impotency and the Compounding Pharmacist |
Vol. 3 No. 2 |
80 |
Medication Combinations for Penile Injections |
Vol. 3 No. 2 |
81 |
Complementary Medical Approaches to Benign Prostatic Hyperplasia |
Vol. 3 No. 2 |
85 |
Natural Testosterone: Hormone of the Heart |
Vol. 3 No. 2 |
88 |
Use of Saw Palmetto and Pygeum in Men |
Vol. 3 No. 2 |
99 |
Case Report: Testosterone Supplementation in a Vasectomy Patient |
Vol. 3 No. 2 |
101 |
An Aftershave Lotion for Pseudofolliculitis Barbae |
Vol. 3 No. 2 |
102 |
Compounding for Athletes: A Primer for Rookies |
Vol. 3 No. 2 |
104 |
Book Reviews |
Vol. 3 No. 2 |
107 |
Natural HRT: Corrective Measures When the System Goes Down |
Vol. 3 No. 2 |
109 |
The Basics of Compounding: Compounding Creams and Lotions |
Vol. 3 No. 2 |
111 |
Profile of a Practice |
Vol. 3 No. 2 |
116 |
Tips for Collecting Mortars and Pestles |
Vol. 3 No. 2 |
118 |
Personal Computing: Take Care When Choosing a Computer Consultant |
Vol. 3 No. 2 |
122 |
Report: USP Expert Advisory Panel on Pharmacy Compounding Practices |
Vol. 3 No. 2 |
126 |
Marketing Tip: Locator Maps |
Vol. 3 No. 2 |
127 |
Athletic-Analgesic Rub |
Vol. 3 No. 2 |
130 |
Dehydroepiandrosterone 50-mg Capsules |
Vol. 3 No. 2 |
131 |
Minoxidil 3% and Finasteride 0.1% Topical Liquid |
Vol. 3 No. 2 |
132 |
Piroxicam 0.5% in Pluronic Lecithin Organogel |
Vol. 3 No. 2 |
133 |
Prostaglandin E1/Papaverine HCl/Phentolamine Mesylate Injection |
Vol. 3 No. 2 |
134 |
Sildenafil Citrate 25-mg Sublingual Troches |
Vol. 3 No. 2 |
135 |
Special Aftershave Preparations |
Vol. 3 No. 2 |
136 |
Testosterone-Menthol Eutectic Ointment (2% Testosterone) |
Vol. 3 No. 2 |
137 |
Testosterone 10-mg Troches |
Vol. 3 No. 2 |
138 |
Testosterone 10-mg/0.1-mL Sublingual Drops |
Vol. 3 No. 2 |
139 |
Preservatives, Featured Excipient: |
Vol. 3 No. 2 |
142 |
Calculations |
Vol. 3 No. 2 |
145 |
Standard Operating Procedure for Quality Assessment of Oral and Topical Liquids |
Vol. 3 No. 2 |
146 |
Analysis of Extemporaneous Alprostadil Formulations |
Vol. 3 No. 2 |
148 |
Stability of Extemporaneously Prepared Sterile Testosterone Solution in 0.9% Sodium Chloride Solution Large-Volume Parenterals in Plastic Bags |
Vol. 3 No. 2 |
156 |
Quantitation of Testosterone Propionate in an Injection Using High Performance Liquid Chromatography |
Vol. 3 No. 2 |
158 |
In Vitro Transdermal Delivery and Stability of Liposome-Encapsulated Prostaglandin E1 |
Vol. 3 No. 2 |
160 |
Compounding and the Specialty Veterinary Practice: An Interview with Gary Riggs, DVM, ABVP |
Vol. 3 No. 3 |
172 |
Call of the Wild: Compounding for Zoos and Exotics |
Vol. 3 No. 3 |
176 |
Improving Profitability with Veterinary Compounding |
Vol. 3 No. 3 |
180 |
Compounding for Creatures: What Works |
Vol. 3 No. 3 |
182 |
The Top Ten Veterinary Compound Preparations |
Vol. 3 No. 3 |
183 |
Veterinary Flavor Suggestions |
Vol. 3 No. 3 |
186 |
When is Compounding for Animals Legal? |
Vol. 3 No. 3 |
188 |
Use of Fenbendazole in Treating Trichuriasis in Colobus Monkeys |
Vol. 3 No. 3 |
193 |
Returning to our Roots |
Vol. 3 No. 3 |
194 |
Value and Pricing: Figuring Out What You're Worth |
Vol. 3 No. 3 |
197 |
Marketing Tip: Teachable Moments: A Simple Concept |
Vol. 3 No. 3 |
199 |
The BPS Pharmacy Specialty Certification Program |
Vol. 3 No. 3 |
200 |
Compounding for Athletes: Tips for Making the Team |
Vol. 3 No. 3 |
206 |
The Basics of Compounding: Compounding Powder-Filled Capsules |
Vol. 3 No. 3 |
209 |
Morphine Sulfate-Dextromethorphan Hydrobromide-Example of capsule with Dry Powder Fill |
Vol. 3 No. 3 |
215 |
Amitriptyline HCl 1-mg/mL Oral Liquid and Gel |
Vol. 3 No. 3 |
218 |
Buspirone HCl 2.5-mg/0.1-mL in PLO for Cats |
Vol. 3 No. 3 |
219 |
General Sulfonamide 150-mg/mL Suspension |
Vol. 3 No. 3 |
220 |
Nonaqueous Nonoleaginous Paste Base |
Vol. 3 No. 3 |
221 |
Phenylpropanolamine HCl 10-mg Chewable Troches for Dogs |
Vol. 3 No. 3 |
222 |
Progesterone 100-mg/mL Veterinary Injection |
Vol. 3 No. 3 |
223 |
Sulfadiazine Sodium 333-mg/mL and Pyrimethamine 16.7-mg/mL Oral Liquid |
Vol. 3 No. 3 |
224 |
Veterinary Antibiotic/Antifungal/Anti-Inflammatory Anesthetic Otic Drop |
Vol. 3 No. 3 |
225 |
Veterinary Electrolyte Injection |
Vol. 3 No. 3 |
226 |
Veterinary Phenobarbital 22-mg/mL Oral Liquid |
Vol. 3 No. 3 |
227 |
Sweetening Agents, Featured Excipient: |
Vol. 3 No. 3 |
228 |
Standard Operating Procedure for Quality Assessment of Powder-Filled, Hard-Gelatin Capsules |
Vol. 3 No. 3 |
232 |
Calculations |
Vol. 3 No. 3 |
234 |
Fosphenytoin Y-site Stability Studies with Lorazepam and Midazolam Hydrochloride |
Vol. 3 No. 3 |
235 |
Quantitation of Testosterone in Suspension using High Performance Liquid Chromatography |
Vol. 3 No. 3 |
239 |
Compatibility of Docetaxel with Selected Drugs during Simulated Y-Site Administration |
Vol. 3 No. 3 |
241 |
Improving the Management, Operations and Cost Effectiveness of Sterile-Product Compounding |
Vol. 3 No. 4 |
253 |
Green IV Nutritionals |
Vol. 3 No. 4 |
260 |
Sterilization and Depyrogenation Principles and Methods |
Vol. 3 No. 4 |
263 |
Book Review-The CIVAS Handbook |
Vol. 3 No. 4 |
269 |
Sterile Product Compounding: A Comparison of ASHP and USP Guidelines |
Vol. 3 No. 4 |
270 |
Extemporaneous Formulations in Pediatric Patients |
Vol. 3 No. 4 |
274 |
Marketing Tip: PR Can Help with Image Change and Geographic Expansion |
Vol. 3 No. 4 |
277 |
Antique Pharmaceutical Balances |
Vol. 3 No. 4 |
280 |
Compounding for Athletes: Common Questions about Sports Medicine |
Vol. 3 No. 4 |
285 |
Profile of a Practice |
Vol. 3 No. 4 |
288 |
The Basics of Compounding: Compounding Special Capsules |
Vol. 3 No. 4 |
291 |
Capsules with Liquid Fill-Sample-Progesterone 100-mg |
Vol. 3 No. 4 |
294 |
Capsules with Semisolid Fill-Sample-Tri-Est |
Vol. 3 No. 4 |
294 |
Calcium Levulinate 15-mg/mL Injection |
Vol. 3 No. 4 |
298 |
Dextrose 20% and Sodium Chloride 20% Sclerosing Injection |
Vol. 3 No. 4 |
299 |
Estradiol 5-mg/mL-in-Oil Injection |
Vol. 3 No. 4 |
300 |
Fentanyl 20-mcg/mL and Bupivacaine HCl 1.25-mg/mL for Pump Administration |
Vol. 3 No. 4 |
301 |
Morphine Sulfate 50-mg/mL Injection |
Vol. 3 No. 4 |
302 |
Parenteral Admixture with Y-Site Administration |
Vol. 3 No. 4 |
303 |
Tri-Est 2.5-mg/mL Aqueous Injection |
Vol. 3 No. 4 |
304 |
Trimethoprim 50-mg/mL Injection |
Vol. 3 No. 4 |
305 |
Vancomycin and Ceftazidime in Peritoneal Dialysis Solution |
Vol. 3 No. 4 |
306 |
Veterinary Prochlorperazine and Isopropamide Injection |
Vol. 3 No. 4 |
307 |
Acidifying Agents, Featured Excipient: |
Vol. 3 No. 4 |
309 |
Calculations |
Vol. 3 No. 4 |
311 |
Standard Operating Procedure for Quality Assessment of Special Hard-Gelatin Capsules |
Vol. 3 No. 4 |
312 |
Quantitation of Testosterone-Cypionate-in-Oil Injection using High Performance Liquid Chromatography |
Vol. 3 No. 4 |
314 |
Stability of Amphotericin B in 5% Dextrose Ophthalmic Solution |
Vol. 3 No. 4 |
316 |
Rapid Pharmacokinetic Evaluation of Topical Drug Formulations |
Vol. 3 No. 4 |
321 |
Interview: Katharina Dalton, MD: Progesterone and Related Topics |
Vol. 3 No. 5 |
332 |
Finding the Balance |
Vol. 3 No. 5 |
340 |
Top Ten HRT Compound Preparations |
Vol. 3 No. 5 |
342 |
Wilson's Syndrome and T3 Therapy |
Vol. 3 No. 5 |
344 |
Assessment and Management of Thermoregulation |
Vol. 3 No. 5 |
350 |
Case Reports: Long-Term Effects of Topical Progesterone Cream Application; Progesterone Suppositories for PMS |
Vol. 3 No. 5 |
352 |
Andropause: Annotated Citations from the Literature |
Vol. 3 No. 5 |
355 |
Women's Health Book Reviews |
Vol. 3 No. 5 |
357 |
Planning and Marketing a Natural HRT Patient Seminar |
Vol. 3 No. 5 |
360 |
Marketing Tip: Collaboration Can Result in More Cost-Effective Seminars |
Vol. 3 No. 5 |
362 |
Preventing Leakage in Oil-Filled Capsules |
Vol. 3 No. 5 |
364 |
Feline Urologic Syndrome and Diet Formulation |
Vol. 3 No. 5 |
366 |
Compounding Practice Structures |
Vol. 3 No. 5 |
368 |
Closing in on 2000: Your Y2K Report |
Vol. 3 No. 5 |
371 |
Chemical Facial Peel Formulations: an Overview |
Vol. 3 No. 5 |
375 |
Jessner's Solution |
Vol. 3 No. 5 |
375 |
Unna's Paste |
Vol. 3 No. 5 |
375 |
Baker-Gordon Formula |
Vol. 3 No. 5 |
376 |
Tamoxifen Citrate - A Potential Therapy for the Treatment of Keloids |
Vol. 3 No. 5 |
380 |
Tamoxifen Citrate Cream 0.1% |
Vol. 3 No. 5 |
381 |
Compounding for Athletes: Successful Sports Compounds |
Vol. 3 No. 5 |
382 |
The Basics of Compounding: Compounding Gels |
Vol. 3 No. 5 |
385 |
Lubricating Jelly Formula |
Vol. 3 No. 5 |
388 |
Poloxamer Gel Base |
Vol. 3 No. 5 |
388 |
Clear Carbomer Gel |
Vol. 3 No. 5 |
388 |
Piroxicam 0.5% in an Alcoholic Gel |
Vol. 3 No. 5 |
389 |
Methylcellulose Gels |
Vol. 3 No. 5 |
389 |
Pluronic Lecithin Organogel (PLO Gel) |
Vol. 3 No. 5 |
389 |
Estriol 0.2-mg/mL in Pluronic Lecithin Organogel |
Vol. 3 No. 5 |
392 |
Ethinyl Estradiol 0.2-mg Gelatin Troches |
Vol. 3 No. 5 |
393 |
Progesterone 50-mg/mL Topical Gel |
Vol. 3 No. 5 |
394 |
Progesterone 100-mg/mL Sublingual Drops |
Vol. 3 No. 5 |
395 |
Progesterone 100-mg Semisolid-Fill, Hard-Gelatin Capsules |
Vol. 3 No. 5 |
396 |
Progesterone 10% Topical Cream |
Vol. 3 No. 5 |
397 |
Progesterone 200-mg/mL in Pluronic Lecithin Organogel |
Vol. 3 No. 5 |
398 |
Testosterone 1-mg Buccal Troches |
Vol. 3 No. 5 |
399 |
Triple Estrogen 2.5-mg, Progesterone 100-mg and Testosterone 1-mg Capsules |
Vol. 3 No. 5 |
400 |
Triple Estrogen 2.5-mg Slow-Release Capsules |
Vol. 3 No. 5 |
401 |
Alkalizing Agents, Featured Excipient: |
Vol. 3 No. 5 |
404 |
Standard Operating Procedure: Quality Assessment for Injectable Solutions |
Vol. 3 No. 5 |
406 |
Calculations |
Vol. 3 No. 5 |
408 |
In Vitro Studies on the Release of Morphine Sulfate from Compounded Slow-Release Morphine-Sulfate Capsules |
Vol. 3 No. 5 |
409 |
Stability of Dobutamine Hydrochloride 4 mg/mL in 5% Dextrose Injection at 5 and 23 degrees C |
Vol. 3 No. 5 |
412 |
Physical Compatibility of Calcium Acetate and Potassium Phosphates in Parenteral Nutrition Solutions Containing Aminosyn II |
Vol. 3 No. 5 |
415 |
Erratum: Stability of an Extemporaneously
Formulated Levothyroxine Sodium Syrup
Compounded from Commercial Tablets
(IJPC 1997:1(1):60-64) |
Vol. 3 No. 6 |
427 |
Prescription- New Cures for Arthritis.pdf |
Vol. 3 No. 6 |
427 |
Glucosamine Sulfate: A Review of Efficacy for the Pharmacy Professional |
Vol. 3 No. 6 |
428 |
Osteoarthritis: Other Options |
Vol. 3 No. 6 |
433 |
Book Reviews: Maximizing the Arthritis Cure: A Step-by-Step Program To Faster, Stronger Healing During Any Stage of the Cure |
Vol. 3 No. 6 |
438 |
Book Reviews: The Arthritis Cure: The Medical Miracle that Can Halt, Reverse, and May Even Cure Osteoarthritis |
Vol. 3 No. 6 |
438 |
Electronically Controlled Drug Delivery |
Vol. 3 No. 6 |
439 |
Case Report: Iontophoresis with Lidocaine and Dexamethasone for Treating Rotator Cuff Injury in a Hockey Player |
Vol. 3 No. 6 |
441 |
Case Reports: Iontophoresis and Phonophoresis for Treating Epicondylitis |
Vol. 3 No. 6 |
441 |
Compounding Radiolabeled Blood Cells for Diagnostic Imaging |
Vol. 3 No. 6 |
443 |
Extemporaneous Formulations: How to Evaluate HPLC Stability Studies |
Vol. 3 No. 6 |
447 |
Marketing Tip: Flavors: Target Marketing to Doctors and Patients |
Vol. 3 No. 6 |
454 |
Book Reviews: Hatherleigh Guide to Psychopharmacology |
Vol. 3 No. 6 |
454 |
Book Reviews: Medical Abbreviations: 14,000 Conveniences at the Expense of Communications and Safety |
Vol. 3 No. 6 |
454 |
Profile of a Practice: Going the Extra Mile with Pharmaceutical Care |
Vol. 3 No. 6 |
455 |
Independent Pharmacists Score High with Consumers |
Vol. 3 No. 6 |
457 |
When Problem Audits Strike |
Vol. 3 No. 6 |
458 |
The Basics of Compounding: Compounding Hard, Soft and Chewable Troches/Lozenges/Drops |
Vol. 3 No. 6 |
461 |
Linguet Base (Soft Lozenge) |
Vol. 3 No. 6 |
462 |
Sorbitol Based Hard Lozenges |
Vol. 3 No. 6 |
462 |
Sucrose Based Hard Lozenges |
Vol. 3 No. 6 |
462 |
Polyethylene Glycol (PEG) Troches (Soft Lozenges) |
Vol. 3 No. 6 |
463 |
Polyethylene Glycol (PEG) Troches with Suspending Agent (Soft Lozenges) |
Vol. 3 No. 6 |
463 |
Chewable Lozenges |
Vol. 3 No. 6 |
464 |
Capsicum and Capsaicin Formulas |
Vol. 3 No. 6 |
468 |
DMSO 70% Topical Solution |
Vol. 3 No. 6 |
469 |
Glucosamine HCl 600-mg Capsules |
Vol. 3 No. 6 |
470 |
Indomethacin 4% Topical Spray |
Vol. 3 No. 6 |
471 |
Iontophoresis Solutions for Arthritis |
Vol. 3 No. 6 |
472 |
Ketoprofen 2.5% in Pluronic Lecithin Organogel |
Vol. 3 No. 6 |
473 |
Methotrexate 2.5-mg/5-mL Oral Liquid |
Vol. 3 No. 6 |
474 |
Methyl Salicylate and Menthol Analgesic Stick |
Vol. 3 No. 6 |
475 |
Piroxicam 1% Alcoholic Gel |
Vol. 3 No. 6 |
476 |
Ultrasonic Preparations for Arthritis |
Vol. 3 No. 6 |
477 |
Viscosity-Increasing Agents for Aqueous Systems, Featured Excipient: |
Vol. 3 No. 6 |
479 |
Calculations |
Vol. 3 No. 6 |
487 |
Operation of a Dry-Heat Sterilizing Oven and Validation of this Procedure |
Vol. 3 No. 6 |
488 |
Calamine Lotion: Experimenting with a New Suspending Agent |
Vol. 3 No. 6 |
490 |
Use of an Oxygen Extractor to Minimize Oxidation of Compounded Preparations |
Vol. 3 No. 6 |
493 |
Enhancement of Skin Penetration of Nonsteroidal Anti-Inflammatory Drugs from Extemporaneously Compounded Topical-Gel Formulations |
Vol. 3 No. 6 |
496 |